课题基金 / 基金详情

项目摘要

项目成果

XIAOHUA HUANG的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们建议将SBS的最佳验证方面与简化的DNA扩增和高速荧光成像方法相结合,以开发和实施快速和廉价的基因组重测序和从头测序平台。我们的平台被称为“自然合成测序”(nSBS)。扩增的DNA分子克隆将通过DNA聚合酶和大部分天然核苷酸合成的循环测序进行大量平行测序。关键是利用一小部分可切割荧光标记的核苷酸与天然核苷酸一起,通过合成过程进行环碱基对碱基DNA测序,以进行序列检测。不仅荧光标记的核苷酸结合是稀疏的,而且荧光部分也将在每个成像步骤后被切割掉。这将最大限度地减少对延伸DNA模板的自然结构的修改,并确保DNA合成不会受到显着影响。使用这种策略,可以对均聚物束进行测序,并且可以实现很长的读取长度。我们提出了一种新的突破性技术的概念,称为自然DNA合成测序(nSBS)。我们还提出了其他几项突破性创新:1)利用微阵列和DNA模板的快速组装来原位大规模平行扩增单个DNA分子。2)使用自动机来验证和优化新的nSBS化学,通过使用DNA聚合酶和市售核苷酸以及我们将设计和合成的核苷酸来进行循环测序;3)反应与检测解耦,使系统可扩展到非常高密度的全基因组测序阵列。由于可以使用更高密度的阵列,并且只使用一种酶(DNA聚合酶),因此所需的试剂要少得多。这将导致吞吐量的显著提高和试剂成本的降低。4)实现双筒对端策略和新的从头序列装配算法。从长远来看,这项技术将具有巨大的潜力,可以实现非常精确的基因组重测序和高速从头测序,并大大降低生物医学研究和个性化医疗的成本。我们建议开发一种突破性的DNA测序技术,称为自然DNA合成DNA测序(nSBS)。我们将把基因组级DNA扩增的简化方法与新的测序化学结合起来,设计出一个超快速、低成本的人类基因组测序平台,从而使个体人类基因组的常规测序可以用于生物医学应用和个性化医疗。
英文摘要
DESCRIPTION (provided by applicant): We propose to combine the best proven aspects of SBS with streamlined methods for DNA amplification and high-speed fluorescence imaging to develop and implement a platform for rapid and inexpensive genome resequencing and de novo sequencing. Our platform is called "Natural Sequencing by Synthesis" (nSBS). Amplified DNA molecular clones will be sequenced in massive parallel by cyclic sequencing by synthesis using DNA polymerases and mostly natural nucleotides. The key is to use a small percentage of a cleavable fluorescently-labeled nucleotide along with the natural nucleotide in the cyclic base-by-base DNA sequencing by synthesis process for sequence detection. Not only will the fluorescently-labeled nucleotide incorporation be sparse but the fluorescent moiety will also be cleaved off after each imaging step. This will minimize the modification of the natural structure of the extending DNA template and ensure that DNA synthesis will not be significantly affected. With this strategy, homopolymer tracts can be sequenced and very long read lengths can be achieved. We present a concept for a new breakthrough technology called natural DNA sequencing by synthesis (nSBS). We also present several other breakthrough innovations: 1) In situ massive parallel amplification of single DNA molecules with micro fabricated arrays and rapid assembly of DNA templates. 2) The usage of an automaton to validate and optimize the new nSBS chemistry for cyclic sequencing by synthesis using DNA polymerases and commercially available nucleotides and nucleotides we will design and synthesize for efficient incorporation; 3) The decoupling of the reaction from detection to make the system scalable to very high-density arrays for whole genome sequencing. Since much higher density arrays can be used and only one enzyme (DNA polymerase) will be used, much less reagent will be needed. This will result in dramatic improvement of throughput and reduction in reagent cost. 4) The implementation of a double barrel paired-end strategy and new algorithms for de novo sequence assembly. In the long run this technology will have a great potential to enable very accurate re-sequencing and de novo sequencing of genomes at high speed and much lower cost for biomedical research and personalized medicine. PROJECT HEALTH RELEVANCE We propose to develop a breakthrough DNA sequencing technology called DNA sequencing by natural DNA synthesis (nSBS). We will combine streamlined methods for genome-scale DNA amplification with the new sequencing chemistry to engineer a sequencing platform for ultra-fast and low-cost human genome sequencing so that routine sequencing of individual human genomes can be performed for biomedical applications and personalized medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanopore Direct Single-Molecule Protein Sequencing
Nanopore Direct Single-Molecule Protein Sequencing
Single-stranded sequencing using microfluidic reactors (SISSOR)
Single-stranded sequencing using microfluidic reactors (SISSOR)
海外基金